Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACAP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
mRNA | ACAP3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ACBD6 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | ACBD7 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ACRBP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ACRV1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-09 |
mRNA | ACVR1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ACVR2B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
mRNA | ADAM15 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |